Chronic Inflammation Features and Causes

Chronic inflammation is not merely a prolonged version of acute inflammation; it is a distinct pathological process central to some of medicine’s most challenging diseases, from rheumatoid arthritis to atherosclerosis. For the MCAT and your medical career, understanding its unique cellular players and destructive-repair cycle is critical, as it bridges basic immunology with systemic pathology and long-term patient outcomes.

The Defining Cellular Infiltrate: Mononuclear Cells

The first hallmark that distinguishes chronic inflammation is its characteristic cellular infiltrate. While acute inflammation is dominated by neutrophils (short-lived granulocytes), chronic inflammation features a mononuclear cell infiltration. This term specifically refers to three key lymphocyte types: macrophages, lymphocytes, and plasma cells.

Macrophages are the unequivocal dominant cell type in chronic inflammation. They are not merely scavengers; they are the central orchestrators. These cells often originate from circulating monocytes that migrate into tissues and differentiate. In chronic settings, macrophages can become activated and may coalesce into granulomas—organized collections of macrophages—in response to persistent stimuli like the bacteria causing tuberculosis. Lymphocytes, including T-cells and B-cells, are recruited and interact with macrophages, driving antigen-specific immune responses. Plasma cells, which are differentiated B-lymphocytes, produce antibodies that can sometimes contribute to the ongoing tissue injury, especially in autoimmune conditions.

Simultaneous Tissue Destruction and Repair

A paradoxical and damaging feature of chronic inflammation is the concurrent processes of tissue destruction and tissue repair. This isn't a sequential "clean-up then rebuild" operation; both happen at the same time, often leading to dysfunctional architecture.

The destruction is mediated directly by the inflammatory cells. Activated macrophages and lymphocytes release a barrage of reactive oxygen species, proteolytic enzymes (like collagenases), and pro-inflammatory cytokines (like TNF-α and IL-1). These substances degrade the extracellular matrix and kill parenchymal cells. Meanwhile, the repair process is also initiated. Macrophages switch phenotypes to release growth factors (like Platelet-Derived Growth Factor - PDGF) and fibrogenic cytokines (most importantly, Transforming Growth Factor-beta - TGF-β). These signals activate fibroblasts to proliferate and produce collagen. The problem is that this repair is often excessive and misdirected, occurring amidst ongoing destruction.

Fibrosis: The End-Stage Scar

The ultimate consequence of the prolonged repair process in chronic inflammation is fibrosis. This is the replacement of normal functional tissue with non-functional, dense, collagen-rich scar tissue. It is a direct result of the sustained activation of fibroblasts by macrophage-derived factors, particularly TGF-β.

Fibrosis is a final common pathway for many chronic diseases. In the liver, chronic viral hepatitis or alcohol exposure leads to cirrhosis. In the lungs, chronic inflammation from conditions like sarcoidosis results in pulmonary fibrosis. In the context of the MCAT, you should link fibrosis to the loss of organ function. For example, cardiac fibrosis after myocarditis impairs the heart's contractility and electrical conduction.

Major Etiologies: The Persistent Triggers

Chronic inflammation arises from specific scenarios where an inflammatory stimulus cannot be quickly eliminated. The core causes are:

1. Persistent Infections: Certain microorganisms evade rapid clearance, eliciting a sustained immune response. The classic example is Mycobacterium tuberculosis, which survives within macrophages, leading to the formation of granulomatous inflammation (tubercles). Other examples include certain viruses (e.g., hepatitis B/C) and parasites.
2. Prolonged Toxic Exposure: Low-level, continuous exposure to toxic agents can cause chronic inflammation. This includes non-degradable exogenous materials like silica dust (silicosis) or asbestos (asbestosis), as well as endogenous toxins like elevated plasma lipid components in atherosclerosis.
3. Autoimmune Diseases: Here, the immune system persistently targets the body's own tissues, creating a self-perpetuating cycle of inflammation. Rheumatoid arthritis (targeting synovial joints) and lupus (targeting multiple systems) are prime examples where lymphocytes and antibodies drive chronic damage.
4. Foreign Body Reactions: Large, inert materials like surgical sutures, silicone breast implants, or bone fragments cannot be phagocytosed. Their continued presence leads to a chronic inflammatory response, often with giant cells (fused macrophages) gathered around the material.

The Orchestrator: The Activated Macrophage

To tie the process together, focus on the macrophage's dual and central role. It is the primary effector cell for both tissue injury and fibrous repair. Upon activation by persistent stimuli or T-cell signals (like IFN-γ), it releases the destructive mediators mentioned earlier. Simultaneously, it secretes the critical growth factors and fibrogenic cytokines that drive tissue remodeling. This includes:

• PDGF and FGF: Stimulate fibroblast proliferation and migration.
• TGF-β: The most potent stimulus for collagen synthesis and deposition by fibroblasts. It also inhibits enzymes that degrade collagen, tipping the balance toward scar formation.

This dual function makes the macrophage the key therapeutic target in modulating chronic inflammatory diseases.

Common Pitfalls

1. Confusing Acute and Chronic Cellular Players: A common MCAT trap is associating neutrophils with chronic inflammation. Remember: neutrophils = acute; mononuclear cells (macrophages, lymphocytes) = chronic.
2. Viewing Destruction and Repair as Separate Phases: Do not conceptualize chronic inflammation as having a clear "destructive phase" followed by a "repair phase." Emphasize that they are concurrent, overlapping processes, which is why the resulting tissue architecture is so disordered.
3. Overlooking the Role of Lymphocytes: While macrophages are dominant, chronic inflammation is often an interplay between innate (macrophages) and adaptive (lymphocytes) immunity. For example, in autoimmune disease, T-cells are crucial for activating macrophages against self-tissue.
4. Misidentifying Causes: Do not attribute chronic inflammation to severe acute injuries alone. While a severe acute insult can transition to chronicity, the key concept is persistence of the stimulus (e.g., a lingering infection, not a one-time burn).

Summary

• Chronic inflammation is defined by an infiltrate of mononuclear cells: predominantly macrophages, along with lymphocytes and plasma cells.
• It involves the paradoxical simultaneous tissue destruction and repair, leading to dysfunctional tissue architecture and eventual fibrosis (scarring).
• It is driven by persistent triggers: persistent infections (e.g., tuberculosis), prolonged toxic exposure (e.g., silica), autoimmune diseases (e.g., rheumatoid arthritis), and foreign body reactions.
• The macrophage is the dominant orchestrator, releasing substances that cause tissue damage while also secreting growth factors and fibrogenic cytokines like TGF-β that drive collagen deposition and fibrosis.
• Understanding this process is foundational for grasping the pathophysiology of major chronic diseases across organ systems, from cirrhosis to pulmonary fibrosis.